24438 Investors following Sun Pharma. Share this News with them.
0
Like this story, share it with millions of investors on M3
Sun Pharma announces approval to mkt Tessalon
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted approval for the Abbreviated New Drug Application (ANDA) to market a generic version of Forest Labs Tessalon, benzonatate capsules.
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted approval for the Abbreviated New Drug Application (ANDA) to market a generic version of Forest Lab's Tessalon, benzonatate capsules.
Benzonatate USP capsules are therapeutically equivalent to Forest Lab's Tessalon, and are available in two strengths: capsules containing 100 mg and 200 mg benzonatate USP.
Benzonatate has annual sales of approximately USD 40 million in the US.
Benzonatate is an antitussive, used to relieve cough due to the common cold, bronchitis, pneumonia, or other lung infections.
|
Budget: 2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | Union Budget | Budget 2012
| Economic Survey
| Railway Budget
| Financial Glossary
|
Message Board |
Moneybhai |
Connect.in.com |
Business Yellow Pages |
India's Premiere Technology Guide | History India
| Up Polls | Latest News
| Suzlon Energy | Rafale | Sun Pharma | Iran | Oil and Natural Gas Corporation | BSE Sensex | Reliance Power | Bonus share | Steel Authority of India Limited | State Bank of India 
